idiopathic pulmonary fibrosis: Idiopathic pulmonary fibrosis (IPF) is a nonneoplastic pulmonary disease that is characterized by the formation of scar tissue within the lungs in the absence of any known cause.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
2788 |
4. Check minimum number of eventsNone |
2788 |
5. Include endpointsNone |
2788 |
6. Filter based on genotype QC (FinnGen only) |
2788 |
Control definitions (FinnGen only)
- Control exclude
- ILD_ENDPOINTS
Extra metadata
- First used in FinnGen datafreeze
- DF5
- Parent code in ICD-10
- J84
- Name in latin
- Morbus pulmonum interstitialis cum fibrosi
Similar endpoints
↥List of similar endpoints to
Idiopathic pulmonary fibrosis
based on the number of shared cases.
Similar with more cases:
- Other interstitial pulmonary diseases
- Interstitial lung disease
- Interstitial lung disease endpoints
- Respiratory diseases principally affecting the interstitium, IBD co-morbidites
- Other respiratory diseases principally affecting the interstitium
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 18549 | 7438 | 10834 |
| Only index persons | 13181 | 5367 | 7814 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.27 | 0.21 | 0.30 |
| Only index persons | 0.26 | 0.20 | 0.30 |
| Median age at first event (years) | |||
| Whole population | 74.28 | 75.14 | 73.71 |
| Only index persons | 74.01 | 74.46 | 73.69 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2788 | 946 | 1842 |
| Unadjusted period prevalence (%) | 0.65 | 0.32 | 0.81 |
| Median age at first event (years) | 71.90 | 69.97 | 72.89 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2495
- Matched controls
- 24947
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
356
Kela drug reimbursment
Nintedanib and pirfenidone
+∞
323.0
384
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
10.8
323.0
907
1257
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
27.3
323.0
882
490
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
25.9
323.0
543
265
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
5490.8
323.0
1043
*
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
+∞
323.0
2495
*
284
Kela drug reimbursment
Nintedanib and pirfenidone
+∞
323.0
461
*
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
+∞
323.0
373
*
TGC00
NOMESCO Finland
Bronchial lavation
31.4
323.0
526
210
L04AX05
ATC
pirfenidone; oral
+∞
322.0
302
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
7.3
312.8
878
1723
H02AB06
ATC
prednisolone; systemic
4.9
285.4
1803
8699
XG410
NOMESCO Finland
Flow-volume spirometry
11.4
232.7
463
487
L01XE31
ATC
[U] nintedanib; oral
+∞
207.2
196
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.6
191.7
1266
5501
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
5.6
188.7
635
1445
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
13.2
186.1
341
295
R06.0
ICD-10 Finland
Dyspnoea
3.7
183.1
1112
4464
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.4
178.4
1641
9012
J96.1
ICD-10 Finland
Chronic respiratory failure
12.6
178.4
334
302
L04AX01
ATC
azathioprine; systemic
11.2
174.3
346
352
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
7.4
171.8
446
715
R03AC02
ATC
salbutamol; inhalant
3.0
146.4
1521
8540
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
148.0
145.0
153
11
L01EX09
ATC
nintedanib; oral
+∞
135.7
129
*
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
71.3
129.3
148
22
GD1AD
NOMESCO Finland
Thorax CT examination
6.8
117.0
315
517
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.6
109.0
416
1030
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
37.0
108.6
140
40
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
5.9
106.3
323
618
L04AA06
ATC
mycophenolic acid; systemic
16.2
105.0
174
115
Z94.2
ICD-10 Finland
Lung transplant status
354.7
102.9
103
*
GDG10
NOMESCO Finland
Bilateral transplantation of lung
512.8
100.2
99
*
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
17.1
84.1
136
84
J84.0
ICD-10 Finland
Alveolar and parietoalveolar conditions
+∞
83.8
80
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.3
82.3
1071
6057
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.6
81.2
309
750
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.2
79.3
472
1675
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
7.0
78.9
205
315
J01MA14
ATC
moxifloxacin; systemic
3.6
76.8
390
1225
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
771.1
76.7
75
*
R03BB04
ATC
tiotropium bromide; inhalant
3.0
76.2
519
2017
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.5
65.6
630
2975
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.2
62.7
207
428
M05BA04
ATC
alendronic acid; oral
3.1
59.1
367
1321
R05
ICD-10 Finland
Cough
2.4
58.7
584
2785
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.4
58.4
582
2778
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
11.2
58.0
112
104
C03CA01
ATC
furosemide; systemic
2.0
56.3
1154
7546
J61
ICD-10 Finland
Pneumoconiosis due to asbestos and other mineral fibres
13.0
55.1
99
79
127
Kela drug reimbursment
Transplant complication
10.3
53.1
107
108
XX4BW
NOMESCO Finland
NA
61.4
51.6
60
10
A02BC02
ATC
pantoprazole; systemic
1.9
51.2
1665
12715
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
3.7
50.3
234
673
P01BA02
ATC
hydroxychloroquine; oral
3.2
49.5
279
932
L04AD01
ATC
ciclosporin; systemic
9.0
49.5
107
123
XG466
NOMESCO Finland
Sleep oxymetry
4.8
48.5
169
370
J43.9
ICD-10 Finland
Emphysema, unspecified
6.9
47.2
122
185
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.1
46.6
629
3414
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.6
46.2
373
1568
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
5.2
45.6
147
295
R28
ICPC
Limited function/disability (R)
8.7
43.8
97
116
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
3.7
43.5
206
600
R4110
NOMESCO Finland
Physiotherapy
2.0
43.4
752
4489
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
14.0
41.1
71
52
J01AA02
ATC
doxycycline; systemic
1.9
41.1
1884
15504
R99
ICPC
Respiratory disease other
7.1
40.6
102
149
J47
ICD-10 Finland
Bronchiectasis
5.9
40.2
117
208
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
40.1
838
5322
J01FA06
ATC
roxithromycin; oral
1.8
40.0
999
6738
WX892
NOMESCO Finland
Monitored bed care
2.7
39.1
297
1198
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.8
38.9
1103
7725
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.2
37.8
448
2268
R03BA08
ATC
ciclesonide; inhalant
3.1
37.2
221
759
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.1
36.3
448
2306
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.8
35.8
756
4777
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.9
35.5
675
4113
J45.9
ICD-10 Finland
Asthma, unspecified
2.1
34.7
483
2609
5150X
ICD-9 Finland
Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]
+∞
34.4
33
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
34.0
489
2677
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
33.9
565
3272
J01MA12
ATC
levofloxacin; systemic
1.9
33.6
584
3436
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
3.3
33.5
177
560
J45.1
ICD-10 Finland
Nonallergic asthma
2.8
33.1
224
840
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
4.2
32.4
127
313
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.7
32.0
145
406
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.8
31.9
213
793
I50.9
ICD-10 Finland
Heart failure, unspecified
1.9
31.6
581
3478
Z3226
NOMESCO Finland
Physiotherapist
1.9
31.5
516
2958
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.9
31.5
205
750
R02
ICPC
Shortness of breath/dyspnoea
2.2
31.0
360
1791
WX721
NOMESCO Finland
Oxygen concentrator therapy
25.7
31.0
43
17
R04.2
ICD-10 Finland
Haemoptysis
3.4
30.8
156
478
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
30.5
596
3631
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
52.1
30.4
36
7
ZX108
NOMESCO Finland
Inhalation
9.4
29.4
61
66
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
4.8
29.4
100
214
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
3.5
28.0
135
398
J84
ICD-10 Finland
Other interstitial pulmonary diseases
284.5
27.8
28
*
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
4.5
27.3
99
226
GD1RA
NOMESCO Finland
Dynamic X-ray examination of respiratory organs with convetional X-ray picture
54.0
27.2
32
6
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
11.3
26.6
50
45
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.6
26.4
830
5797
J94.1
ICD-10 Finland
Fibrothorax
37.1
26.2
33
9
GX1K5
NOMESCO Finland
Diffusion capacity
40.5
25.8
32
8
L04AA13
ATC
leflunomide; oral
4.6
25.7
92
208
WX725
NOMESCO Finland
Noninvasive ventilation
3.1
25.7
147
493
GDA10
NOMESCO Finland
Biopsy of lung
24.3
25.7
36
15
D86.0
ICD-10 Finland
Sarcoidosis of lung
7.8
25.5
59
77
R03AK08
ATC
formoterol and beclometasone; inhalant
3.6
25.0
116
332
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.4
24.9
222
970
F1246
NOMESCO Finland
NA
17.2
24.9
39
23
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
4.9
24.8
83
175
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
5.3
24.7
77
150
A02BC05
ATC
esomeprazole; systemic
1.6
24.5
920
6701
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
22.2
24.3
35
16
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.2
24.3
132
427
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.6
24.2
184
736
XG460
NOMESCO Finland
Short time oxymetry
4.2
23.9
94
233
Z51.5
ICD-10 Finland
Palliative care
2.3
23.8
233
1067
J92.9
ICD-10 Finland
Pleural plaque without asbestos
5.2
23.7
75
149
L01AA01
ATC
cyclophosphamide; systemic
12.2
23.3
42
35
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
7.5
23.2
55
75
R03BA02
ATC
budesonide; inhalant
1.9
23.1
407
2371
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.2
23.1
264
1299
M34.9
ICD-10 Finland
Systemic sclerosis, unspecified
24.9
23.0
32
13
R05
ICPC
Cough
1.8
23.0
487
3011
WX872
NOMESCO Finland
Intensive care
2.5
22.8
180
738
XJC10
NOMESCO Finland
Oesophageal pH monitoring
11.5
22.7
42
37
J99.0*M05.1
ICD-10 Finland
Rheumatoid lung disease
232.0
22.6
23
*
J43.8
ICD-10 Finland
Other emphysema
17.7
22.6
35
20
WW200
NOMESCO Finland
Immunization
4.0
22.6
93
241
A07EC01
ATC
sulfasalazine; oral, rectal
2.3
22.6
213
959
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
22.5
995
7492
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
7.3
22.5
54
75
M05BA07
ATC
risedronic acid; oral
3.1
22.1
125
414
5AB14
NOMESCO Finland
NA
52.5
22.1
26
5
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
2.2
21.8
240
1160
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.0
21.8
325
1776
GX1D5
NOMESCO Finland
Flow volume spirometry
116.0
21.6
23
*
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
5.9
21.5
60
103
RS123
NOMESCO Finland
NA
43.7
21.4
26
6
J01CA04
ATC
amoxicillin; systemic
1.5
21.4
1730
14852
A02BC03
ATC
lansoprazole; oral
1.6
21.0
736
5217
F2680
NOMESCO Finland
NA
15.6
21.0
34
22
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
12.0
21.0
38
32
N02AX02
ATC
tramadol; systemic, rectal
1.5
20.9
1034
7943
H02AB07
ATC
prednisone; oral
1.8
20.8
381
2240
I50.0
ICD-10 Finland
Congestive heart failure
2.0
20.8
308
1679
R5140
NOMESCO Finland
Monitoring the use of the aid
2.0
20.7
276
1443
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.4
20.7
181
781
L04AA01
ATC
[U] ciclosporin; systemic
5.1
20.6
65
129
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
3.6
20.6
93
262
A07AA02
ATC
nystatin; oral
2.3
20.5
194
875
R03AK07
ATC
formoterol and budesonide; inhalant
1.8
20.3
397
2385
A02BC01
ATC
omeprazole; systemic
1.6
20.0
726
5178
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
2.6
19.9
155
628
2AX04
NOMESCO Finland
NA
36.0
19.8
25
7
WX726
NOMESCO Finland
High-flow oxygen therapy
29.2
19.6
26
9
3A006
NOMESCO Finland
NA
201.5
19.6
20
*
XW5WT
NOMESCO Finland
Other blood specimen with radiologicl guidance
19.5
19.5
29
15
R03BA05
ATC
fluticasone; inhalant
1.8
19.4
400
2438
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
7.6
19.4
45
60
I27.8
ICD-10 Finland
Other specified pulmonary heart diseases
15.7
19.3
31
20
Z2446
NOMESCO Finland
Social worker
2.4
19.1
165
709
Z2221
NOMESCO Finland
Medical doctor
1.6
18.9
652
4581
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
3.9
18.7
79
210
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.4
18.7
91
272
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.2
18.3
187
873
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.2
18.1
200
968
C07AB07
ATC
bisoprolol; oral
1.5
18.0
1324
10923
ZXE00
NOMESCO Finland
One hour or less
1.5
17.7
896
6846
J67.9
ICD-10 Finland
Hypersensitivity pneumonitis due to unspecified organic dust
22.9
17.7
25
11
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.5
17.5
137
557
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
3.5
17.3
82
241
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
17.3
488
3249
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
4.6
17.2
60
134
J01FA10
ATC
azithromycin; systemic
1.5
17.0
1022
8071
Z57.2
ICD-10 Finland
Occupational exposure to dust
9.8
16.6
33
34
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.2
16.5
182
879
XG474
NOMESCO Finland
Exhalation nntrogen oxide
3.8
16.5
71
193
J99.1
ICD-10 Finland
Respiratory disorders in other diffuse connective tissue disorders
40.3
16.3
20
5
Z3231
NOMESCO Finland
Registered nurse
1.5
16.3
673
4904
J96.0
ICD-10 Finland
Acute respiratory failure
3.9
16.2
67
176
TPH07
NOMESCO Finland
Cathetrisation of artery
1.8
16.2
301
1772
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
2.9
16.1
98
345
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.2
16.0
173
826
R03BA01
ATC
beclometasone; inhalant
1.7
16.0
327
1984
J80
ICD-10 Finland
Adult respiratory distress syndrome
10.1
15.9
31
31
ZX120
NOMESCO Finland
Intravenous
1.9
15.9
254
1421
WX722
NOMESCO Finland
PEEP
2.3
15.9
147
653
M34.1
ICD-10 Finland
CR(E)ST syndrome
14.6
15.8
26
18
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
8.0
15.8
35
44
XJC02
NOMESCO Finland
Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter
10.5
15.7
30
29
R50.9
ICD-10 Finland
Fever, unspecified
1.7
15.3
338
2096
N02AA01
ATC
morphine; systemic, rectal
3.7
15.2
66
181
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
15.2
635
4629
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
9.5
14.9
30
32
XX9XE
NOMESCO Finland
Other ultrasound examination
7.2
14.8
35
49
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.8
14.7
274
1611
B01AA03
ATC
warfarin; systemic
1.5
14.7
702
5255
J67.0
ICD-10 Finland
Farmer lung
25.2
14.7
20
8
J43.2
ICD-10 Finland
Centrilobular emphysema
10.5
14.2
27
26
AN1
HP
Coronary angiography
1.6
14.1
395
2611
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.5
14.1
496
3468
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
14.0
462
3185
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.6
13.8
382
2520
M34.0
ICD-10 Finland
Progressive systemic sclerosis
23.9
13.8
19
8
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
3.1
13.6
74
243
M05BB03
ATC
alendronic acid and colecalciferol; oral
3.1
13.6
75
249
J99.0
ICD-10 Finland
Rheumatoid lung disease
75.5
13.6
15
*
M05.1
ICD-10 Finland
Rheumatoid lung disease
+∞
13.5
13
*
M34.8
ICD-10 Finland
Other forms of systemic sclerosis
34.2
13.5
17
5
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
4.3
13.4
49
116
5BA08
NOMESCO Finland
NA
7.3
13.2
31
43
R81
ICPC
Pneumonia
2.5
13.1
104
429
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.0
13.1
172
894
XG499
NOMESCO Finland
Other fysiological examination of respiatory function
9.4
13.0
26
28
R03AC03
ATC
terbutaline; inhalant
1.7
12.6
280
1735
NH3EA
NOMESCO Finland
Feet X-ray examination with load
3.7
12.6
54
148
1CX01
NOMESCO Finland
NA
15.5
12.6
20
13
GDA97
NOMESCO Finland
Other thoracoscopic incision, excision of lesion or repair of lung
70.2
12.6
14
*
RK320
NOMESCO Finland
NA
4.7
12.6
42
91
J01FA15
ATC
telithromycin; oral
1.9
12.5
187
1023
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.4
12.5
650
4919
R03DC03
ATC
montelukast; oral
1.7
12.4
282
1760
J93.1
ICD-10 Finland
Other spontaneous pneumothorax
4.7
12.3
41
89
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.1
12.1
141
697
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
6.6
12.0
30
46
SPAT1262
SPAT
Handing over of treatment supplies
1.5
12.0
462
3285
RK110
NOMESCO Finland
NA
4.8
11.9
39
83
FXD00
NOMESCO Finland
Use of ECHLA without concurrent surgical procedure
46.9
11.9
14
*
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
3.0
11.8
67
226
A01AB09
ATC
miconazole; local oral
1.8
11.7
213
1245
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.8
11.6
197
1125
GX2C5
NOMESCO Finland
Short-lasting oximetry
19.0
11.6
17
9
D07AB02
ATC
hydrocortisone butyrate; topical
1.4
11.5
578
4337
Z3229
NOMESCO Finland
Other healthcare associate professional
1.7
11.5
223
1326
5163A
ICD-9 Finland
Other alveolar and parietoalveolar pneumopathy, Idiopathic fibrosing alveolitis
+∞
11.5
11
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
11.4
868
7002
AK3
HP
BLTX (both lung transplants)
120.5
11.4
12
*
C10AA03
ATC
pravastatin; oral
1.7
11.4
221
1316
WZA10
NOMESCO Finland
Long statement of health and health related matters
4.5
11.3
39
88
J82
ICD-10 Finland
Pulmonary eosinophilia, not elsewhere classified
8.9
11.2
23
26
C01DA14
ATC
isosorbide mononitrate; oral
1.4
11.2
560
4196
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
2.3
11.2
101
449
I73.0
ICD-10 Finland
Raynaud syndrome
4.3
11.2
40
94
XG405
NOMESCO Finland
Education on PEF monitoring
3.8
11.0
46
124
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.2
11.0
57
182
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.4
11.0
704
5511
R03BB01
ATC
ipratropium bromide; inhalant
2.0
10.8
144
751
J20
ICD-10 Finland
Acute bronchitis
1.8
10.8
204
1205
R06AE07
ATC
cetirizine; oral
1.4
10.8
769
6126
GAA31
NOMESCO Finland
Thoracoscopy
8.3
10.8
23
28
WZC30
NOMESCO Finland
Teaching
1.6
10.8
288
1875
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
1.6
10.8
285
1851
D07AC01
ATC
betamethasone; topical
1.4
10.8
729
5758
R4190
NOMESCO Finland
Nutritional therapy
2.8
10.8
68
248
ZX197
NOMESCO Finland
NA
28.1
10.7
14
5
D86.2
ICD-10 Finland
Sarcoidosis of lung with sarcoidosis of lymph nodes
5.9
10.7
29
50
H02AB04
ATC
methylprednisolone; systemic
1.6
10.7
320
2144
GX2D5
NOMESCO Finland
Sleep oximetry
12.9
10.6
18
14
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.6
10.6
76
299
E0000UV
ATC
NA
1.4
10.6
785
6288
G47.3
ICD-10 Finland
Sleep apnoea
1.5
10.5
433
3114
J01FF01
ATC
clindamycin; systemic
1.4
10.5
566
4289
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
10.5
573
4353
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.7
10.4
204
1219
Z94.3
ICD-10 Finland
Heart and lungs transplant status
110.4
10.4
11
*
J99.1*M35.0
ICD-10 Finland
Respiratory disorders in sicca syndrome [Sjögren]
+∞
10.4
10
*
E84.9
ICD-10 Finland
Cystic fibrosis, unspecified
+∞
10.4
10
*
XX2XT
NOMESCO Finland
Other injection with other radiological guidance
7.7
10.4
23
30
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
5.0
10.3
32
65
SPAT1325
SPAT
Vaccination
1.3
10.3
860
7014
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
6.4
10.3
26
41
R29
ICPC
Respiratory symptom/complaint other
2.0
10.3
128
654
M33.1
ICD-10 Finland
Other dermatomyositis
18.8
10.3
15
8
M81.4
ICD-10 Finland
Drug-induced osteoporosis
8.5
10.0
21
25
WX740
NOMESCO Finland
Nitrogen oxide therapy
14.6
10.0
16
11
R06.2
ICD-10 Finland
Wheezing
2.2
9.9
97
448
A02BA02
ATC
ranitidine; systemic
1.4
9.9
487
3628
R05FB02
ATC
cough suppressants and expectorants
1.3
9.9
856
7012
J01FA09
ATC
clarithromycin; systemic
1.4
9.8
548
4171
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
9.8
388
2763
4040
NOMESCO Finland
NA
20.1
9.8
14
7
XF402
NOMESCO Finland
ECG with work load test
1.6
9.6
282
1881
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
4.2
9.5
35
85
M33.9
ICD-10 Finland
Dermatopolymyositis, unspecified
15.1
9.5
15
10
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.9
9.5
130
690
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.2
9.5
99
470
E84.0
ICD-10 Finland
Cystic fibrosis with pulmonary manifestations
100.4
9.4
10
*
J99.1*M34.8
ICD-10 Finland
Respiratory disorders in systemic: sclerosis
100.4
9.4
10
*
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.8
9.4
156
887
M33.2
ICD-10 Finland
Polymyositis
12.4
9.3
16
13
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
4.4
9.3
32
73
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
2.5
9.3
70
283
A02BA03
ATC
famotidine; systemic
2.0
9.2
120
625
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
9.2
312
2151
M35.1
ICD-10 Finland
Other overlap syndromes
7.3
9.2
21
29
XX4AW
NOMESCO Finland
NA
13.7
9.2
15
11
318
Kela drug reimbursment
Teriparatide
6.7
9.1
22
33
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.3
9.1
699
5605
WX882
NOMESCO Finland
High dependency care
2.4
9.1
76
327
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.6
9.1
226
1445
XPX04
NOMESCO Finland
Angioscopy
9.1
9.0
18
20
J70.2
ICD-10 Finland
Acute drug-induced interstitial lung disorders
10.1
9.0
17
17
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
3.4
9.0
42
126
A28
ICPC
Limited function/disability NOS
1.4
8.9
446
3323
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
2.8
8.9
54
194
H05AA02
ATC
teriparatide; parenteral
7.5
8.9
20
27
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.1
8.8
101
498
WX720
NOMESCO Finland
Own respiration
2.2
8.8
85
393
JN4BD
NOMESCO Finland
Extensive body CT
1.5
8.7
272
1837
C02KX01
ATC
bosentan; oral
50.1
8.7
10
*
81
HP
Angiography of the heart and coronary arteries
1.6
8.7
231
1502
R03BB07
ATC
umeclidinium bromide; inhalant
4.5
8.6
29
65
XJC00
NOMESCO Finland
Oesophageal manometry
6.6
8.6
21
32
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.8
8.6
158
924
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
1.8
8.6
151
874
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
3.1
8.6
44
142
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.0
8.6
104
528
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
2.0
8.5
104
529
J98.9
ICD-10 Finland
Respiratory disorder, unspecified
16.3
8.5
13
8
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
1.8
8.5
155
907
L88
ICPC
Rheumatoid/seropositive arthritis
2.2
8.5
80
365
C08CA02
ATC
felodipine; oral
1.5
8.4
273
1861
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.9
8.4
125
686
M35.8
ICD-10 Finland
Other specified systemic involvement of connective tissue
12.8
8.4
14
11
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.7
8.4
176
1076
5169X
ICD-9 Finland
Other alveolar and parietoalveolar pneumopathy, Unspecified alveolar and parietoalveolar pneumopathy
+∞
8.3
8
*
J01XB01
ATC
colistin; inhalant, parenteral
+∞
8.3
8
*
R05CB13
ATC
dornase alfa (desoxyribonuclease); inhalant
+∞
8.3
8
*
304
Kela drug reimbursment
Dornase alfa
+∞
8.3
8
*
N02BE01
ATC
paracetamol; systemic, rectal
1.3
8.3
1933
17976
RK250
NOMESCO Finland
NA
5.5
8.3
23
42
I27.0
ICD-10 Finland
Primary pulmonary hypertension
9.5
8.3
16
17
R01AD09
ATC
mometasone; nasal
1.3
8.3
735
6009
C09AA05
ATC
ramipril; oral
1.3
8.3
683
5524
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
6.0
8.1
21
35
ZXA10
NOMESCO Finland
Bilateral
1.4
8.1
436
3290
XF600
NOMESCO Finland
Bloodpressure measurement
1.7
8.1
153
906
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
3.6
8.0
34
95
M13.9
ICD-10 Finland
Arthritis, unspecified
1.8
8.0
135
773
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.8
8.0
125
697
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
2.9
8.0
46
160
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
2.1
7.9
86
419
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
2.7
7.8
50
186
J02AC03
ATC
voriconazole; systemic
10.8
7.8
14
13
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
7.8
746
6152
N02AA05
ATC
oxycodone; systemic
1.4
7.7
386
2870
J99.1*M33.2
ICD-10 Finland
Respiratory disorders in polymyositis
45.1
7.7
9
*
L04AB01
ATC
etanercept; parenteral
4.3
7.7
27
64
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.6
7.7
179
1125
RS230
NOMESCO Finland
NA
5.3
7.7
22
42
11
HP
Coronary artery bypass surgery
2.0
7.7
95
487
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.4
7.6
321
2312
T86.8
ICD-10 Finland
Failure and rejection of other transplanted organs and tissues
18.4
7.6
11
6
J15.8
ICD-10 Finland
Other bacterial pneumonia
4.0
7.6
28
70
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
1.9
7.5
106
568
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
2.5
7.5
56
227
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
1.5
7.5
265
1838
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.3
7.5
615
4952
L01BB01
ATC
NA
10.0
7.5
14
14
M06
ICD-10 Finland
Other rheumatoid arthritis
5.4
7.5
21
39
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
3.4
7.5
34
101
M01CB01
ATC
sodium aurothiomalate; parenteral
2.9
7.5
44
156
XX1AW
NOMESCO Finland
Written report from X-ray examination without contrast peformed elsewhere
4.8
7.4
23
48
4038
NOMESCO Finland
NA
80.3
7.4
8
*
FXE00
NOMESCO Finland
Use of ECLA
80.3
7.4
8
*
J67.8
ICD-10 Finland
Hypersensitivity pneumonitis due to other organic dusts
80.3
7.4
8
*
C02KX04
ATC
macitentan; oral
80.3
7.4
8
*
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.6
7.4
181
1152
GX1E5
NOMESCO Finland
Flow volume spirometry and bronchodilation test
13.4
7.4
12
9
I84.1
ICD-10 Finland
Internal hemorrhoids with other complications
2.4
7.3
59
252
WX302
NOMESCO Finland
Thoracal epidural anesthesy
1.8
7.3
118
668
2770A
ICD-9 Finland
Other and unspecified disorders of metabolism, Cystic fibrosis
+∞
7.3
7
*
R03AC12
ATC
salmeterol; inhalant
1.8
7.3
119
674
F03
ICD-10 Finland
Unspecified dementia
0.5
7.2
40
869
J93.8
ICD-10 Finland
Other pneumothorax
5.2
7.2
21
41
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
5.2
7.2
21
41
RK310
NOMESCO Finland
NA
15.8
7.2
11
7
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
7.2
869
7372
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.5
7.2
221
1487
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
3.5
7.2
31
89
XQ800
NOMESCO Finland
Prick test
1.9
7.2
97
515
FXF00
NOMESCO Finland
Decannulation after ECHLA or ECLA
30.1
7.1
9
*
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
2.8
7.1
43
156
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
5.0
7.1
21
42
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.7
7.1
157
974
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.8
7.1
121
697
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.4
7.0
288
2062
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.4
7.0
288
2066
R03AC19
ATC
olodaterol; inhalant
5.2
6.9
20
39
L01CB
ATC
Podophyllotoxin derivatives
7.5
6.9
15
20
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
2.7
6.8
42
155
J01DB01
ATC
cefalexin; oral
1.3
6.8
1730
15994
S22.2
ICD-10 Finland
Fracture of sternum
5.3
6.8
19
36
C10AA01
ATC
simvastatin; oral
1.2
6.8
1193
10563
J45.8
ICD-10 Finland
Mixed asthma
2.1
6.8
73
357
R03AK11
ATC
formoterol and fluticasone; inhalant
2.5
6.7
51
210
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.5
6.7
237
1650
I25.2
ICD-10 Finland
Old myocardial infarction
1.5
6.7
234
1623
R01AD12
ATC
fluticasone furoate; nasal
1.4
6.7
399
3058
M05BA06
ATC
ibandronic acid; systemic
2.6
6.7
47
185
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.5
6.7
205
1382
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
1.6
6.7
158
1001
E000001
ATC
NA
1.4
6.7
391
2985
NG1DA
NOMESCO Finland
X-ray of knees
2.7
6.7
43
161
FN1YT
NOMESCO Finland
Percutaneous insertion of coronary artery stent
1.6
6.6
173
1123
A03
ICPC
Fever
1.5
6.6
219
1502
J12.8
ICD-10 Finland
Other viral pneumonia
3.7
6.6
26
70
L04AA24
ATC
abatacept; parenteral
10.0
6.5
12
12
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
2.6
6.5
46
182
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
3.0
6.5
35
119
Z31.5
ICD-10 Finland
Genetic counselling
2.3
6.5
56
248
C61
ICD-10 Finland
Malignant neoplasm of prostate
0.7
6.5
171
2468
R2110
NOMESCO Finland
Giving the first information
1.8
6.5
109
627
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.5
6.5
51
984
J17.1*B25.0
ICD-10 Finland
Cytomegaloviral pneumonitis
70.0
6.4
7
*
602
Kela drug reimbursment
Children's severe malnutrition
70.0
6.4
7
*
J99.1*M31.3
ICD-10 Finland
Respiratory disorders in Wegener's granulomatosis
14.3
6.4
10
7
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
2.7
6.4
39
144
ZXE10
NOMESCO Finland
More than one and less than three hours
1.3
6.4
777
6577
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
3.0
6.3
33
110
J93.0
ICD-10 Finland
Spontaneous tension pneumothorax
8.2
6.3
13
16
M05BX04
ATC
denosumab; parenteral
1.8
6.3
111
646
XQ841
NOMESCO Finland
Examination of dermatosis with microscope
18.0
6.3
9
5
E84.8
ICD-10 Finland
Cystic fibrosis with other manifestations
+∞
6.2
6
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.6
6.2
153
976
TNB11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in shoulder joint
4.3
6.2
21
49
N03AX12
ATC
gabapentin; oral
1.4
6.2
280
2043
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
4.8
6.2
19
40
1240
FHL
Bronchoscopy
2.7
6.2
38
141
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
3.8
6.2
24
64
C08CA05
ATC
nifedipine; systemic
1.5
6.1
177
1178
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
0.7
6.1
163
2353
RS220
NOMESCO Finland
NA
3.0
6.1
32
107
ECB20
NOMESCO Finland
Oral alveoplasty
3.3
6.1
28
85
J92
ICD-10 Finland
Pleural plaque
12.5
6.1
10
8
R06AX22
ATC
ebastine; oral
1.4
6.1
243
1734
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
6.1
509
4099
B01AC04
ATC
clopidogrel; oral
1.3
6.1
454
3598
XG467
NOMESCO Finland
Nocturnal CO2 monitoring
8.6
6.0
12
14
A01AB04
ATC
amphotericin B; local oral
1.7
6.0
112
663
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
6.7
6.0
14
21
M01CC01
ATC
penicillamine; oral
10.0
6.0
11
11
XF614
NOMESCO Finland
Measurement of pulmonary artery pressure
10.0
6.0
11
11
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.4
6.0
285
2098
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
424
547
8.96
315.71
2.4
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
326
299
12.21
311.47
3.0
2.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
565
906
7.57
307.65
3.8
2.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
331
131
28.54
307.65
2.8
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
969
2182
6.27
307.65
1.5
1.3
titre
616.7
507.2
0.93
321
467
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
367
349
11.96
307.65
2.5
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
746
1791
5.32
300.97
4.2
4.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
315
290
12.12
300.01
2.5
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
401
523
8.79
295.36
2.9
1.5
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
516
893
6.86
295.02
1.4
1.7
u/ml
14.9
20.6
—
8
28
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
194
71
29.29
288.69
1.1
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
404
553
8.37
285.54
2.8
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
875
2800
4.10
238.84
1.4
1.2
iu/ml
72.3
38.5
3.57
301
870
(3000492) Spirometry study
619
1541
4.88
234.80
3.4
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
312
408
8.48
227.84
2.9
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
253
260
10.60
222.36
3.3
1.5
—
—
—
0
0
(44790047)
240
229
11.37
222.09
3.3
1.4
—
—
—
0
0
(44806118)
240
229
11.37
222.09
3.3
1.4
—
—
—
0
0
(44790048)
240
229
11.37
222.09
3.3
1.4
—
—
—
0
0
(44790049)
240
229
11.37
222.09
3.3
1.4
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
900
3090
3.82
219.71
9.1
6.7
kpa
5.1
5.1
0.18
858
2919
(3027801) Oxygen [Partial pressure] in Arterial blood
899
3090
3.82
219.02
9.1
6.7
kpa
9.8
11.9
41.14
859
2922
(3006184) Hemoglobin [Mass/volume] in Capillary blood
367
601
6.88
218.99
2.4
2.2
g/l
131.7
127.4
1.18
131
454
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
395
698
6.43
218.73
1.7
1.5
titre
286.6
214.7
0.25
29
34
(42870588) Differential panel, method unspecified - Blood
1552
7537
3.39
217.68
11.6
5.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
897
3091
3.80
217.52
9.1
6.7
mmol/l
1.7
1.1
4.87
734
2360
(3015171) Extractable nuclear Ab [Units/volume] in Serum
349
555
7.04
214.00
1.3
1.2
u/ml
1.1
0.4
0.61
40
48
(4010399)
591
1526
4.65
212.82
2.1
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
147
60
25.81
209.93
2.7
1.4
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
1888
10541
3.45
205.60
11.8
5.2
e9/l
0.7
0.6
13.11
1751
8902
(3006315) Basophils [#/volume] in Blood
1893
10609
3.44
204.34
11.8
5.3
e9/l
0.0
0.0
5.36
1756
8977
(3013115) Eosinophils [#/volume] in Blood
1927
10942
3.46
202.96
12.6
5.5
e9/l
0.2
0.2
6.17
1801
9393
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
279
368
8.31
201.79
18.6
4.6
iu/ml
455.5
5141.4
0.49
82
47
(3022096) Basophils/100 leukocytes in Blood
1787
9739
3.33
200.86
12.3
5.6
%
0.6
0.6
1.09
1743
8950
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
260
319
8.89
199.51
2.9
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
259
320
8.82
197.60
1.8
1.4
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
1894
10794
3.35
195.02
11.9
5.4
e9/l
1.9
1.9
0.06
1766
9298
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
241
279
9.36
193.48
1.9
1.4
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
1797
10012
3.24
190.68
12.5
5.6
%
2.8
2.9
0.62
1754
9190
(3019069) Monocytes/100 leukocytes in Blood
1800
10050
3.23
190.05
13.0
5.9
%
8.9
9.0
1.46
1754
9254
(3002030) Lymphocytes/100 leukocytes in Blood
1801
10218
3.15
181.69
12.7
5.8
%
24.1
25.6
7.34
1754
9347
(3018010) Neutrophils/100 leukocytes in Blood
1778
10044
3.13
180.18
12.2
5.5
%
60.8
58.9
8.84
1731
9246
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
763
2683
3.54
174.90
1.3
1.2
u/ml
34.5
12.6
1.62
200
936
(3005719) IgG [Mass/volume] in Serum or Plasma
533
1465
4.26
174.72
3.9
2.7
g/l
10.6
10.7
0.19
507
1319
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
100
20
51.82
174.07
3.6
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
299
509
6.46
170.69
2.0
1.6
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
102
32
33.05
158.64
4.1
4.8
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
302
570
5.82
154.68
1.7
1.4
iu/ml
13.2
9.7
—
18
10
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
235
348
7.28
152.86
1.2
1.2
u/ml
31.8
2.5
1.52
27
24
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
259
432
6.51
150.47
1.3
1.2
titre
73.8
126.0
—
13
10
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
256
424
6.55
149.75
1.3
1.2
u/ml
10.4
7.5
0.25
56
65
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
254
419
6.57
149.15
1.3
1.2
u/ml
2.6
3.6
0.40
40
40
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
259
445
6.31
146.02
1.3
1.2
u/ml
26.2
39.1
0.32
15
19
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
780
3078
3.13
144.73
3.0
1.8
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
734
2811
3.19
143.23
10.0
6.9
%
93.6
95.3
9.56
706
2688
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
775
3095
3.08
140.32
2.9
1.8
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
426
1160
4.15
139.76
2.3
1.9
g/l
1.1
1.5
3.13
398
1036
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
216
324
7.14
138.66
1.4
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
983
4497
2.83
138.43
3.1
1.9
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
1928
12369
2.81
137.17
14.7
8.4
e9/l
5.0
4.4
20.29
1805
10679
(3024471) HLA-A [Type]
89
34
27.01
129.70
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
89
34
27.01
129.70
1.0
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
195
282
7.36
129.29
3.8
3.5
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
198
293
7.20
128.56
7.8
2.4
u/ml
918.5
2838.7
0.68
15
20
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
464
1425
3.71
127.67
11.4
8.4
mmol/l
24.9
24.2
3.61
425
1313
(3042631) Mycobacterium sp identified in Specimen
218
363
6.43
126.49
3.1
2.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
203
320
6.76
124.20
1.4
1.3
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
113
82
14.32
123.27
3.9
1.9
ug/l
32.8
65.4
2.90
113
77
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
186
272
7.26
122.01
1.3
1.3
u/ml
141.8
132.4
0.09
34
46
(4306422)
160
199
8.47
120.66
1.3
1.2
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
158
194
8.57
120.40
1.2
1.1
%
118.3
114.0
0.73
153
177
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
200
322
6.61
119.85
1.1
1.1
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
198
318
6.63
118.92
1.3
1.3
u/ml
36.6
16.4
—
5
7
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
317
791
4.39
116.00
1.5
1.8
u/l
37.0
38.4
0.54
283
668
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1189
6442
2.47
113.66
6.4
3.0
u/l
30.7
37.1
3.24
1149
6089
(3001964) Herpes simplex virus Ag [Presence] in Specimen
90
51
18.20
111.53
3.4
1.3
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
100
73
14.17
108.64
48.8
23.6
ug/l
173.0
109.4
7.70
83
59
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
150
198
7.95
107.53
1.2
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
75
31
24.83
106.09
1.2
1.6
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
157
222
7.43
106.00
1.2
1.2
u/ml
5.8
3.3
0.30
62
71
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
152
212
7.53
103.86
1.2
1.2
u/ml
3.7
5.9
0.74
91
99
(3000494) Fungus identified in Specimen by Culture
600
2426
2.88
102.82
3.0
1.4
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
223
475
5.02
98.86
1.8
1.4
g/l
0.2
0.2
2.80
213
449
(3013637) Mi-2 Ab [Presence] in Serum
77
41
19.29
98.12
1.2
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
77
41
19.29
98.12
1.2
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
77
41
19.29
98.12
1.2
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
77
41
19.29
98.12
1.2
1.1
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
225
494
4.87
96.19
1.8
1.4
g/l
1.2
1.2
0.63
217
467
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
149
223
7.00
95.45
2.3
1.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
113
122
9.61
95.00
1.1
1.1
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
317
912
3.79
94.80
1.6
1.2
u/ml
258.3
223.8
0.26
291
830
(3008152) Bicarbonate [Moles/volume] in Arterial blood
465
1710
3.06
93.95
7.5
6.6
mmol/l
25.1
24.4
3.15
443
1589
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
73
38
19.70
93.94
1.4
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
151
236
6.71
92.85
2.3
1.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
1276
7627
2.24
91.76
5.5
4.4
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1766
12076
2.26
90.39
11.8
6.0
umol/l
11.4
12.6
4.13
1723
11422
(3002173) Hemoglobin [Mass/volume] in Arterial blood
592
2537
2.69
89.56
11.7
7.4
g/l
126.2
120.0
9.32
570
2437
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
212
486
4.64
85.82
1.5
1.9
mg/l
10.2
13.6
2.53
194
437
(3039162) Centromere protein B Ab [Units/volume] in Serum
130
189
7.17
85.46
1.3
1.2
u/ml
39.9
71.8
—
13
8
(3026250) Tacrolimus [Mass/volume] in Blood
77
54
14.64
85.43
42.5
32.1
ug/l
8.3
6.7
5.16
68
49
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
230
565
4.35
85.27
3.7
2.1
%
88.2
87.6
0.16
223
541
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
105
119
9.13
85.04
2.2
1.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
115
147
8.12
84.57
2.1
1.4
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
234
587
4.26
84.38
3.3
2.3
g/l
3.9
3.6
1.54
228
548
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1362
8553
2.16
84.30
4.4
3.2
ng/l
1699.7
1963.5
1.39
1245
7445
(3004616) Nuclear Ab [Presence] in Serum
144
238
6.33
83.80
1.3
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
104
120
8.96
83.06
2.2
1.5
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
214
513
4.44
81.82
3.8
2.3
%
208.9
204.0
0.29
203
487
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
114
152
7.78
80.87
1.1
1.1
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
156
292
5.60
79.78
1.3
1.1
u/ml
59.1
48.7
0.24
26
23
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
108
138
8.10
79.42
2.2
2.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
105
132
8.23
78.26
1.1
1.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
469
1909
2.75
77.63
6.0
3.9
%
0.7
0.9
1.58
168
599
(4268621)
109
145
7.78
77.46
2.2
2.3
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
107
141
7.85
76.65
1.2
1.1
u/ml
71.8
2.0
—
6
5
(3024139) IgG subclass 3 [Mass/volume] in Serum
107
142
7.80
76.19
1.4
1.2
g/l
0.5
0.4
1.97
73
103
(3028192) IgG subclass 2 [Mass/volume] in Serum
107
142
7.80
76.19
1.4
1.2
g/l
3.3
2.9
0.96
73
104
(3027135) IgG subclass 1 [Mass/volume] in Serum
107
142
7.80
76.19
1.4
1.2
g/l
8.0
7.0
1.13
71
102
(4062490)
107
144
7.69
75.27
1.4
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
431
1707
2.80
75.03
5.8
3.8
%
0.4
0.6
1.07
131
421
(3034426) Prothrombin time (PT)
66
45
15.00
74.30
1.1
1.3
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
109
153
7.37
73.90
1.2
1.1
u/ml
41.2
44.3
—
5
16
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
108
153
7.30
72.61
1.2
1.1
u/ml
63.6
77.1
—
5
8
(3030905) Polymorphonuclear cells [#/volume] in Blood
173
385
4.72
72.48
4.3
3.1
e9/l
4.8
4.6
0.73
173
385
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
177
402
4.63
72.32
4.4
3.4
%
59.6
59.4
0.06
177
402
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
418
1665
2.78
71.79
6.7
3.5
mmol/l
2.4
1.9
2.28
343
1189
(3018418) pH of Serum or Plasma
1166
7249
2.05
70.37
5.1
4.0
ph
7.4
7.4
0.50
253
1377
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
429
1752
2.71
70.09
7.0
3.6
kpa
5.2
5.1
1.06
414
1594
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
563
2621
2.44
70.00
4.7
3.0
ng/l
230.1
265.6
1.02
538
2406
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1598
11125
2.02
69.95
9.7
6.0
mmol/l
1.2
1.2
5.86
1495
9976
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
139
266
5.45
69.32
1.1
1.2
u/ml
357.3
275.3
1.49
101
149
(3009343) pH of Capillary blood
423
1728
2.71
69.01
7.0
3.6
ph
7.4
7.4
4.52
64
214
(3024980) IgG subclass 4 [Mass/volume] in Serum
131
239
5.70
68.79
1.6
1.5
g/l
1.0
0.9
0.25
94
184
(40757373) Influenza virus identified in Isolate
73
67
11.16
68.71
3.5
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
771
4151
2.19
67.70
8.8
4.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
821
4546
2.14
66.98
2.6
1.6
mg/l
1.8
1.6
0.73
672
3533
(46235355) HIV 1 and 2 tests - Meaningful Use set
454
1952
2.58
66.65
1.5
1.5
—
—
—
0
0
(3036489) Thrombin time
242
746
3.46
64.55
3.6
1.9
s
21.6
21.8
0.11
225
681
(3025159) Blasts/100 leukocytes in Blood
404
1674
2.65
63.79
6.0
3.9
%
0.0
0.3
0.95
136
457
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
139
288
5.03
63.33
1.1
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
291
1016
3.08
63.22
1.4
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
423
1806
2.58
62.77
6.0
3.9
%
0.1
0.1
0.52
158
555
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
114
200
5.90
62.34
2.3
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
210
615
3.61
60.52
6.0
3.9
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
2036
15862
2.05
60.12
10.0
4.1
mm/h
19.5
14.5
29.49
1973
14441
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
321
1234
2.81
58.43
2.2
1.9
ug/l
1.4
2.6
1.19
290
1064
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1673
12257
1.91
58.31
10.5
6.8
mmol/l
1.2
1.2
2.32
1419
10237
(3007164) IgA [Mass/volume] in Serum or Plasma
618
3217
2.18
57.91
2.0
1.5
g/l
3.0
2.8
1.84
455
1829
(3015235) Bicarbonate [Moles/volume] in Capillary blood
232
747
3.30
57.60
5.5
3.0
mmol/l
25.7
25.0
1.61
216
646
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
104
183
5.86
56.68
1.2
1.1
u/ml
—
—
—
0
0
(40758558) Short blood count panel - Blood
895
5407
1.97
55.57
10.8
6.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
152
376
4.22
55.54
1.2
1.2
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
505
2467
2.28
55.05
13.4
6.6
mmol/l
10.0
11.6
5.92
475
2330
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
78
106
7.54
54.35
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
78
106
7.54
54.35
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
78
106
7.54
54.35
1.2
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
87
134
6.67
54.11
2.3
2.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
345
1429
2.61
54.07
16.4
8.9
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
206
643
3.38
53.70
6.0
2.7
kpa
7.6
7.8
0.92
201
590
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
89
142
6.44
53.51
4.2
3.5
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
78
108
7.40
53.47
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
78
108
7.40
53.47
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
78
108
7.40
53.47
1.2
1.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1322
9146
1.85
53.42
18.9
10.4
e9/l
0.0
0.0
0.26
1152
7395
(3021901) Oxygen saturation in Capillary blood
187
553
3.55
53.01
5.3
2.6
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
703
3965
2.03
52.65
9.0
2.9
mmol/l
0.8
0.8
3.63
653
3674
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
107
209
5.28
52.10
1.5
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
107
209
5.28
52.10
1.5
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
107
209
5.28
52.10
1.5
1.6
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
63
71
9.06
51.14
2.9
1.9
u/ml
110464.8
43484.7
0.24
12
11
(3017143) Hepatitis C virus Ab [Presence] in Serum
367
1614
2.47
50.55
1.5
1.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
624
3420
2.06
50.27
3.0
2.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
45
32
14.28
49.38
1.1
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
376
1696
2.41
48.90
1.5
1.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
46
35
13.35
48.57
1.1
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
64
80
8.16
47.85
1.1
1.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
603
3347
2.02
46.50
12.9
6.3
mmol/l
103.9
104.4
1.64
587
3251
(40767503) Oxygen content in Capillary blood by calculation
184
591
3.26
45.70
3.6
2.5
%
15.9
15.8
0.07
102
303
(3047181) Lactate [Moles/volume] in Blood
228
831
2.90
45.51
7.1
6.1
mmol/l
1.4
1.3
0.92
211
733
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
68
98
7.09
44.96
1.1
1.2
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
95
191
5.11
44.76
1.2
1.4
—
1456.0
—
0
5
(3022313) Gas panel - Capillary blood
294
1241
2.53
43.96
7.2
3.8
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
84
156
5.52
43.22
1.3
1.1
—
—
—
0
0
(4015189)
57
71
8.17
42.73
1.9
2.0
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
86
165
5.35
42.71
1.8
2.2
e9/l
0.9
1.0
0.20
58
92
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2090
17203
1.86
42.59
15.3
7.5
u/l
77.5
81.9
4.50
2042
16033
(3012501) Base excess in Blood by calculation
179
593
3.16
42.20
8.7
4.9
mmol/l
3.2
2.7
1.33
144
401
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
71
116
6.25
41.70
1.7
2.2
%
15.9
16.9
0.15
30
44
(3019977) pH of Arterial blood
84
164
5.25
40.92
2.8
2.6
ph
7.4
7.4
0.26
56
49
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
271
1150
2.50
39.95
4.9
5.1
%
1.9
1.6
4.95
256
1079
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
794
5038
1.81
39.80
5.2
4.2
ng/l
615.7
605.9
0.02
719
4415
(3010421) pH of Blood
193
698
2.90
38.98
8.5
4.6
ph
7.4
7.4
0.72
175
581
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
98
228
4.42
38.74
1.1
1.2
miu/ml
224.9
205.4
—
9
65
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
55
74
7.56
38.64
1.1
1.2
ratio
1.0
1.1
0.18
19
26
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
67
112
6.10
38.47
1.9
2.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
164
550
3.11
37.84
1.6
1.5
iu/ml
130.4
11.4
0.91
47
133
(3026782) Osmolality of Urine
790
5076
1.78
37.57
4.2
2.9
mosm/kgh2o
551.3
558.0
0.45
709
4316
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
427
2252
2.06
37.18
2.0
2.1
g/l
0.2
0.2
2.64
402
2079
(3024561) Albumin [Mass/volume] in Serum or Plasma
1410
10616
1.66
37.15
6.2
4.7
g/l
33.1
34.4
14.68
1309
9766
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
58
88
6.71
36.58
1.7
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
1418
10787
1.64
35.11
12.9
11.6
inr
1.3
1.4
0.84
435
2895
(36304419) Bacteria [Presence] in Urine
957
6616
1.68
34.29
5.2
3.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
75
155
4.94
34.25
1.6
1.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
1070
7616
1.66
34.25
5.4
3.6
e6/l
45.0
115.5
2.63
898
6023
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
162
581
2.90
33.18
1.6
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
162
581
2.90
33.18
1.6
1.3
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
44
56
7.97
32.39
1.1
1.1
u/ml
4.5
11.8
—
8
6
(3018572) Chloride [Moles/volume] in Blood
161
592
2.82
31.48
6.4
7.0
mmol/l
103.9
105.3
3.50
148
528
(3039000) Anion gap in Blood
161
592
2.82
31.48
6.4
7.0
mmol/l
11.8
11.1
1.92
148
528
(3000850) Epithelial cells [#/volume] in Urine
808
5452
1.68
31.15
4.1
2.7
e6/l
4.1
4.4
0.30
737
4807
(3030467) Casts [#/volume] in Urine by Automated count
976
6916
1.63
31.02
5.3
3.4
e6/l
0.4
0.5
1.23
804
5356
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
49
75
6.63
30.65
1.3
2.0
%
116.2
91.2
3.90
49
70
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
55
96
5.82
30.23
1.5
1.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
55
96
5.82
30.23
1.5
1.8
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1715
13944
1.60
30.19
9.6
4.9
mmol/l
6.8
6.9
1.15
1638
13138
(3036481) Cortisol [Moles/volume] in Serum or Plasma
341
1781
2.04
30.14
2.0
2.1
nmol/l
364.1
370.8
0.15
320
1591
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
59
111
5.41
29.96
1.6
1.3
u/ml
0.9
1.7
0.45
41
57
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
64
130
5.02
29.83
1.5
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
64
130
5.02
29.83
1.5
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
64
130
5.02
29.83
1.5
1.6
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1033
7478
1.61
29.77
4.1
2.2
u/l
137.5
235.1
4.33
965
6947
(3014111) Lactate [Moles/volume] in Serum or Plasma
417
2346
1.91
29.72
12.8
6.2
mmol/l
1.4
1.4
0.06
391
2251
(3018095) Leukocytes [#/volume] in Urine
1148
8526
1.59
29.67
6.5
4.0
e6/l
150.0
121.4
0.24
917
6384
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
55
98
5.71
29.60
1.5
1.8
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
356
1902
2.00
29.51
1.8
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
63
130
4.94
28.84
1.5
1.6
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
26
18
14.57
28.80
1.6
1.7
—
—
—
0
0
(3020891) Body temperature
233
1069
2.29
28.61
5.4
4.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
397
2240
1.90
27.94
14.3
7.4
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
240
1134
2.22
27.43
5.4
5.2
%
0.9
0.9
0.58
225
1064
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
35
43
8.23
26.51
1.0
1.5
%
95.4
76.8
1.73
25
28
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
56
114
4.99
26.06
1.8
2.1
e6/l
421.8
518.6
0.45
48
99
(3003458) Phosphate [Moles/volume] in Serum or Plasma
537
3401
1.72
25.52
7.7
5.5
mmol/l
1.0
1.0
0.14
493
3131
(3004789) Transferrin [Mass/volume] in Serum or Plasma
587
3810
1.68
25.46
2.5
2.5
g/l
2.2
2.2
0.06
544
3504
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
54
109
5.03
25.37
1.8
2.1
e9/l
0.2
0.2
0.32
48
97
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
34
43
7.99
25.15
1.0
1.2
%
100.6
90.5
0.56
34
37
(3008536) Aspergillus sp Ab [Presence] in Serum
35
46
7.69
25.07
1.3
1.5
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
620
4097
1.66
25.06
2.5
2.5
umol/l
11.6
12.2
1.28
586
3766
(3033658) Prothrombin time (PT) actual/Normal
813
5748
1.58
24.90
6.8
4.0
%
84.0
82.6
0.77
800
5602
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
310
1675
1.96
24.69
16.4
8.1
%
1.4
1.3
1.73
304
1662
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
559
3612
1.68
24.56
2.5
2.6
%
20.7
22.0
1.57
455
3051
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
308
1665
1.96
24.49
16.6
8.2
%
0.6
0.7
0.31
302
1652
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
32
39
8.29
24.38
1.0
1.1
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
33
42
7.94
24.28
1.0
1.1
%
95.7
79.1
2.30
23
26
(3002032) Base excess in Venous blood by calculation
429
2595
1.77
23.85
4.3
3.5
mmol/l
2.3
1.9
1.33
351
2052
(3021447) Carbon dioxide [Partial pressure] in Venous blood
430
2605
1.77
23.78
4.3
3.5
kpa
5.9
5.8
0.89
410
2517
(3018405) Lactate [Moles/volume] in Arterial blood
204
962
2.21
23.38
4.4
3.7
mmol/l
1.3
1.4
0.80
199
944
(3037467) Urinalysis macro (dipstick) panel - Urine
1814
15395
1.51
22.68
7.0
4.6
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
31
40
7.83
22.55
1.0
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1118
8636
1.49
22.13
3.0
2.2
nmol/l
76.0
78.8
2.87
1027
7445
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
213
1050
2.11
21.79
4.1
2.5
u/ml
0.3
0.3
0.16
127
596
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
412
2529
1.74
21.62
2.6
2.7
umol/l
9.8
10.1
0.07
360
2233
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
212
1047
2.11
21.59
8.3
4.0
mmol/l
25.2
24.7
1.72
201
944
(3018677) aPTT in Platelet poor plasma by Coagulation assay
597
4043
1.61
21.45
3.0
1.9
s
29.8
30.2
0.92
582
3908
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
35
55
6.43
21.37
1.8
2.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
38
66
5.82
21.02
1.7
2.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
37
63
5.94
20.89
1.1
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
309
1775
1.83
20.25
2.0
1.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
589
4026
1.59
20.21
4.6
3.2
e6/l
1.5
1.7
0.57
369
2326
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
193
949
2.11
19.87
4.4
2.2
ug/l
313.8
562.4
1.88
184
891
(3026493) Urate [Moles/volume] in Serum or Plasma
842
6246
1.50
19.81
6.1
2.9
umol/l
1102.8
6699.3
7.55
738
5255
(3019832) Treponema pallidum Ab [Presence] in Serum
138
606
2.34
18.72
1.3
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
289
1668
1.82
18.60
1.6
1.6
%
1.6
1.6
0.26
252
1388
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
23
26
8.91
18.55
1.7
1.2
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
169
811
2.15
18.52
4.9
3.8
mmol/l
4.0
3.9
0.30
157
741
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1218
9796
1.43
18.46
5.3
4.3
ng/l
46.1
59.6
1.33
988
7702
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
120
498
2.47
18.45
2.1
1.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
155
720
2.22
18.42
1.6
1.7
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
1764
15195
1.44
18.10
6.8
5.1
e6/l
519.6
1832.3
1.15
29
293
(3020630) Protein [Mass/volume] in Serum or Plasma
378
2383
1.68
17.78
2.0
2.5
g/l
66.5
66.0
0.56
341
2146
(3035350) Ketones [Presence] in Urine by Test strip
1296
10595
1.42
17.65
5.0
4.0
estimate
0.0
0.0
0.00
322
1973
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
278
1611
1.81
17.63
1.6
1.5
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
50
132
3.84
16.81
1.1
1.2
titre
76.7
130.4
—
9
25
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
228
1265
1.87
16.61
4.0
3.6
mmol/l
24.5
24.0
1.28
202
1117
(3021601) Nitrite [Presence] in Urine by Test strip
1287
10583
1.40
16.57
7.0
5.4
estimate
0.0
0.0
0.50
329
1977
(3015377) Calcium [Moles/volume] in Serum or Plasma
1025
8113
1.42
16.41
4.5
3.3
mmol/l
2.3
2.3
1.09
918
6872
(3004588) Protein electrophoresis panel - Serum or Plasma
321
1987
1.70
16.11
1.9
2.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1858
16317
1.42
15.97
37.7
21.7
%
14.4
14.0
26.95
1841
15892
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
327
2041
1.68
15.90
4.1
3.9
mmol/l
1.2
1.2
2.19
298
1776
(3009261) Glucose [Presence] in Urine by Test strip
1297
10733
1.39
15.81
5.1
4.0
estimate
0.0
0.0
0.80
321
1925
(3024891) Influenza virus A+B Ag [Presence] in Specimen
110
475
2.37
15.54
1.3
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
151
750
2.07
15.15
4.1
3.5
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
19
22
8.69
15.01
1.0
1.1
%
100.3
77.4
—
6
9
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
914
7193
1.40
14.73
3.0
2.5
u/l
61.3
58.8
0.62
860
6579
(3027945) Reticulocytes/100 erythrocytes in Blood
488
3451
1.50
13.81
2.7
2.3
%
1.9
1.8
1.74
424
2998
(44806071)
15
14
10.77
13.75
1.0
1.1
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
18
22
8.23
13.63
1.0
1.1
%
83.8
79.8
—
5
8
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
22
35
6.33
13.28
1.4
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
290
1843
1.64
13.08
5.4
4.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
576
4286
1.43
12.41
4.3
3.0
e6/l
0.8
1.2
3.11
364
2560
(40768797) Stomach Pathology biopsy report
423
2968
1.50
12.33
1.3
1.3
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
447
3192
1.48
11.92
3.8
3.9
u/l
287.0
246.8
3.58
413
2992
(3023520) Reticulocytes [#/volume] in Blood
375
2589
1.52
11.78
2.5
2.4
e9/l
68.0
67.6
0.09
260
1997
(3015736) pH of Urine
1011
8311
1.34
11.72
4.3
3.7
—
6.1
—
0
6
(3024354) Oxygen [Partial pressure] in Venous blood
320
2153
1.55
11.31
3.8
2.9
kpa
4.4
4.5
0.02
303
2071
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
378
2636
1.50
11.30
4.9
3.9
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
700
5479
1.37
11.05
5.1
3.8
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
17
25
6.84
11.02
1.1
1.2
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
224
1411
1.64
10.44
4.3
3.4
mmol/l
25.7
25.0
2.01
214
1371
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
38
119
3.22
9.99
2.1
2.6
%
40.7
35.6
0.75
20
45
(3000060) B lymphocytes [#/volume] in Blood
17
28
6.10
9.92
1.7
2.0
e6/l
2432.2
227.1
—
9
7
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
61
249
2.48
9.86
1.1
1.1
g/l
1.6
1.6
0.03
51
227
(3051651) Icteric interference index of Serum or Plasma
42
141
3.01
9.84
6.3
3.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
822
6689
1.32
9.82
2.4
2.3
mg/l
3.2
3.1
0.44
721
5616
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
17
29
5.89
9.59
1.1
1.2
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
39
128
3.08
9.51
2.3
2.4
mmol/l
8.5
9.5
0.93
30
104
(3004119) Hemoglobin [Mass/volume] in Venous blood
254
1693
1.55
9.34
4.1
3.1
g/l
127.0
126.8
0.03
245
1651
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1038
8766
1.29
9.33
3.1
2.8
ug/l
186.5
163.7
1.66
948
7892
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
50
191
2.65
9.27
1.1
1.1
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
25
62
4.06
9.24
1.4
1.8
ug/l
18.5
154.8
0.51
25
53
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
38
126
3.04
9.12
1.8
2.0
e6/l
576.9
638.1
0.20
21
58
(40760888) Immunoglobulin light chains.free panel - Serum
127
716
1.81
8.86
2.3
3.6
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
93
473
2.00
8.86
1.1
1.1
titre
132.0
97.1
—
10
31
(3047007) Chlamydophila sp Ab [Presence] in Serum
47
180
2.64
8.69
1.3
1.2
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
157
948
1.70
8.63
2.5
3.4
mg/l
39.1
70.8
1.36
117
787
(3034860) Kappa light chains.free [Mass/volume] in Serum
157
949
1.69
8.60
2.5
3.4
mg/l
75.9
61.5
0.50
119
783
(3011397) Hemoglobin [Presence] in Urine by Test strip
647
5171
1.33
8.59
4.3
3.9
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
165
1013
1.67
8.53
2.1
2.5
g/l
3.2
3.1
1.17
125
805
(3029075) Extractable nuclear Ab panel - Serum
21
49
4.31
8.40
1.0
1.0
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
90
463
1.98
8.32
4.3
3.9
%
1.2
1.8
0.72
75
343
(3007853) Bacteria identified in Skin by Aerobe culture
375
2763
1.41
8.30
2.2
1.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1376
12164
1.26
8.14
4.9
3.1
u/l
65.2
56.9
1.49
1286
10995
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
144
864
1.70
8.12
1.3
1.3
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
30
94
3.22
7.94
9.6
2.0
mg/l
63.9
62.0
0.07
25
65
(3037756) Immunofixation for Serum or Plasma
114
646
1.80
7.86
1.5
1.6
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
97
523
1.89
7.83
2.1
2.3
umol/l
31.3
34.2
0.44
83
420
(3026008) Bacteria identified in Urine by Culture
908
7670
1.27
7.80
3.9
3.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
174
1109
1.61
7.77
2.1
2.4
g/l
4.1
3.8
0.98
122
790
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
174
1110
1.61
7.75
2.1
2.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
174
1111
1.60
7.72
2.1
2.4
g/l
8.0
7.4
3.14
126
812
(3026389) Candida sp identified in Specimen by Organism specific culture
59
266
2.24
7.71
1.4
1.4
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
150
924
1.66
7.68
2.5
3.4
ratio
6.8
2.5
0.71
12
69
(3044889) 12 lead EKG panel
1688
15337
1.25
7.64
6.2
4.4
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
135
810
1.70
7.63
2.1
2.4
g/l
0.0
0.0
0.28
122
730
(3020491) Glucose [Moles/volume] in Blood
42
163
2.60
7.60
2.4
2.3
mmol/l
7.4
7.2
0.13
36
104
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
82
423
1.97
7.56
1.2
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
181
1173
1.58
7.55
2.8
1.9
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
214
3094
0.67
7.47
9.9
8.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1110
9642
1.25
7.41
2.9
2.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
83
434
1.94
7.36
1.6
1.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
717
5933
1.28
7.17
5.3
4.3
estimate
0.0
0.0
0.69
303
1850
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
10
5
20.06
7.13
1.0
1.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
947
8122
1.25
6.96
5.2
4.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
74
380
1.97
6.94
1.4
1.4
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
162
1052
1.57
6.72
2.1
2.4
g/l
10.7
10.3
0.66
131
889
(3017732) Neutrophils [#/volume] in Blood
200
1364
1.50
6.64
3.0
3.4
e9/l
4.8
4.3
1.28
161
953
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
99
570
1.76
6.52
2.6
2.7
mg/l
1.8
1.8
0.12
88
502
(3034770) Mitochondria Ab [Titer] in Serum
87
483
1.83
6.47
1.1
1.1
titre
1192.0
967.7
—
5
13
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
145
927
1.60
6.44
2.2
2.6
g/l
0.7
1.2
0.83
124
780
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2200
20774
1.28
6.43
34.4
17.9
mg/l
25.3
28.1
4.83
2070
17148
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
164
1081
1.55
6.39
2.5
1.8
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
58
282
2.08
6.34
1.5
1.5
%
56.8
65.1
0.80
34
180
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
21
61
3.46
6.28
1.8
2.2
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
124
770
1.64
6.21
2.1
2.4
g/l
0.0
0.0
0.00
111
694
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
122
757
1.64
6.13
2.1
2.4
g/l
0.0
0.0
0.00
111
692
(3003327) Ova and parasites identified in Stool by Light microscopy
88
500
1.78
6.09
2.1
1.6
—
—
—
0
0
(4035726)
264
1939
1.40
5.94
1.3
1.3
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
134
860
1.59
5.88
2.1
2.3
g/l
35.7
37.2
2.38
117
729
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
109
665
1.67
5.86
1.5
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
53
257
2.08
5.86
5.9
3.4
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
18
50
3.62
5.76
1.6
1.3
ug/l
8.3
9.4
0.45
18
50
(3045788) Cell count panel - Pleural fluid
64
335
1.93
5.74
1.6
1.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
202
1425
1.45
5.69
1.7
1.7
g/l
1.6
1.5
0.82
165
1201
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
336
2584
1.34
5.67
2.6
2.5
ug/l
13.7
7.1
5.13
295
2197
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
72
395
1.84
5.61
1.1
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
20
61
3.30
5.58
1.3
1.5
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
81
466
1.76
5.41
1.3
1.3
mmol/l
69.9
61.6
0.97
73
370
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
14
34
4.13
5.35
1.3
1.6
—
—
—
0
0
(3004451) EKG impression Narrative
33
139
2.39
5.14
1.5
1.2
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
8
6
13.37
5.08
1.0
1.0
s
32.9
36.0
—
8
6
(3000475) Leukocytes [#/volume] in Synovial fluid
96
591
1.65
5.04
1.7
1.6
e6/l
14471.1
15751.5
0.06
71
424
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
267
2023
1.35
4.98
2.5
2.4
u/l
33.9
41.0
1.27
242
1712
(3036782) Glucose [Moles/volume] in Pleural fluid
60
324
1.87
4.95
1.5
1.4
mmol/l
6.2
6.5
0.34
53
305
(1761868) Lipid panel - Serum or Plasma
461
5567
0.79
4.81
3.1
3.4
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
44
216
2.05
4.77
1.8
1.4
%
47.1
23.9
3.14
24
134
(3023430) Cat dander IgE Ab [Units/volume] in Serum
22
79
2.80
4.71
1.0
1.1
u/ml
1.4
3.0
0.59
12
27
(3019309) Folate [Moles/volume] in Red Blood Cells
656
5611
1.22
4.62
1.8
1.8
nmol/l
1116.6
1166.9
0.70
504
4164
(3012441) Differential panel - Pleural fluid
65
370
1.77
4.56
1.7
1.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
35
163
2.16
4.37
1.7
2.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
434
3571
1.26
4.37
1.2
1.2
u/ml
1.4
1.8
0.85
114
878
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
22
83
2.66
4.32
1.0
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
225
2938
0.75
4.29
4.7
4.8
%
32.7
33.3
0.37
169
1885
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
58
329
1.78
4.15
1.5
1.3
u/l
451.3
322.0
1.08
53
313
(3034891) Synovial lining cells/100 cells in Synovial fluid
25
103
2.44
4.13
1.6
1.3
%
5.3
3.6
—
7
24
(21494755) Public health laboratory ask at order entry panel
29
608
0.47
4.12
1.1
1.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
71
428
1.68
4.10
1.7
1.4
e6/l
7111.3
1662.7
0.56
51
307
(3044941) Cell count panel - Synovial fluid
66
390
1.71
4.10
1.8
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
54
301
1.81
4.09
4.9
4.7
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
68
410
1.68
3.94
1.1
1.1
u/ml
22.8
14.9
—
5
29
(3025941) Bacteria identified in Stool by Culture
145
1034
1.42
3.94
1.4
1.3
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
77
485
1.60
3.77
1.7
1.5
g/l
33.0
30.6
1.19
67
433
(3028308) Erythrocytes [#/volume] in Pleural fluid
65
393
1.67
3.74
1.7
1.4
e6/l
141367.5
66180.2
0.70
42
236
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
49
274
1.80
3.71
1.2
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
29
137
2.13
3.55
4.4
3.3
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
17
63
2.71
3.49
1.1
1.0
u/ml
8.2
2.7
—
6
8
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
19
75
2.54
3.46
1.1
1.0
u/ml
0.5
0.7
—
9
22
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
78
505
1.56
3.44
1.3
1.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
29
140
2.08
3.37
1.0
1.1
u/ml
4.8
3.4
0.12
14
61
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
16
59
2.72
3.32
4.9
8.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
179
1364
1.33
3.29
2.5
2.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
63
392
1.62
3.29
2.1
3.3
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
56
339
1.67
3.25
12.9
7.1
mmol/l
7.3
7.6
0.23
48
277
(3014133) Dog dander IgE Ab [Units/volume] in Serum
20
84
2.39
3.22
1.1
1.0
u/ml
5.2
1.1
0.53
13
27
(3000570) Elastase.pancreatic [Mass/mass] in Stool
94
645
1.47
3.19
1.4
1.5
ug/g
256.5
271.6
0.34
63
391
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1945
20286
0.86
3.11
5.1
5.1
mmol/l
6.1
6.1
1.44
1725
17916
(3048689) Calprotectin [Mass/mass] in Stool
237
1892
1.28
3.10
1.9
2.0
ug/g
146.7
160.4
0.30
192
1453
(40768795) Lymph node Pathology biopsy report
36
195
1.86
3.06
1.2
1.1
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
6
8
7.51
3.05
1.2
1.0
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
6
8
7.51
3.05
1.2
1.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1901
19851
0.87
3.05
4.7
4.8
mmol/l
4.3
4.4
2.46
1682
17886
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
8
16
5.01
3.05
1.1
1.2
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
8
16
5.01
3.05
1.1
1.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1880
19646
0.87
3.04
4.7
4.7
mmol/l
1.4
1.4
1.31
1644
17540
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
57
355
1.62
2.99
1.2
1.3
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
9
21
4.30
2.99
1.6
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
9
21
4.30
2.99
1.6
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
9
21
4.30
2.99
1.6
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
231
1850
1.27
2.96
3.4
2.9
ml/min/173m2
54.3
59.5
1.62
107
815
(3000012) Reticulocyte production index
29
148
1.97
2.94
1.5
1.5
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
30
155
1.95
2.94
1.1
1.1
u/ml
0.6
2.5
1.13
15
60
(40768806) Pleura Pathology biopsy report
59
373
1.59
2.92
1.6
1.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1967
20464
0.87
2.88
5.2
5.4
mmol/l
2.4
2.5
3.47
1737
18335
(3044009) aPTT.lupus sensitive (LA screen)
7
13
5.40
2.87
1.6
1.2
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
7
13
5.40
2.87
1.1
1.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
811
8940
0.87
2.86
4.2
4.8
%
22.3
22.3
0.00
341
4820
(3012516) Albumin [Mass/volume] in Urine
828
7489
1.15
2.85
3.5
3.3
mg/l
659.2
256.7
1.35
556
4864
(3009542) Hematocrit [Volume Fraction] of Blood
1861
17763
1.14
2.81
35.3
19.4
%
38.4
38.3
0.13
1137
10676
(3008401) Mugwort IgE Ab [Units/volume] in Serum
27
137
1.98
2.80
1.0
1.1
u/ml
0.7
0.7
0.02
14
57
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
28
516
0.54
2.79
1.7
1.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
45
269
1.68
2.78
2.6
2.8
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
15
59
2.55
2.78
1.2
1.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
16
66
2.43
2.71
6.6
2.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
83
576
1.45
2.71
1.3
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
43
257
1.68
2.67
1.2
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
34
190
1.80
2.66
1.5
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
83
581
1.44
2.60
1.3
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
546
4820
1.17
2.59
2.8
3.1
mmol/l
2.5
2.5
6.23
477
4188
(3017354) Segmented neutrophils/100 leukocytes in Blood
48
299
1.62
2.56
5.7
3.9
%
56.3
58.2
0.24
33
184
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
34
193
1.77
2.54
1.5
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
83
584
1.43
2.54
1.3
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
53
806
0.65
2.51
1.7
1.8
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
26
136
1.92
2.50
1.2
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
37
217
1.71
2.48
1.3
1.3
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
22
110
2.01
2.40
1.0
1.0
u/ml
2.0
1.9
—
10
26
(3017704) Immunofixation for Urine
30
167
1.81
2.40
1.4
1.5
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
6
12
5.01
2.40
2.5
1.9
%
1.3
1.9
—
6
12
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
9
27
3.34
2.39
1.6
1.1
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
19
90
2.12
2.38
3.6
4.0
%
62.4
53.9
1.12
19
85
(3009508) Creatinine [Moles/volume] in Urine
829
7579
1.13
2.37
3.4
3.2
mmol/l
7.3
7.3
0.01
679
6200
(3044927) Protein electrophoresis panel - Urine
51
330
1.56
2.35
1.3
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
43
267
1.62
2.35
1.0
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
865
7935
1.13
2.34
4.2
4.0
mg/mmol
13.8
9.3
1.60
551
5083
(3019150) Specific gravity of Urine by Refractometry
543
4831
1.15
2.32
5.1
4.4
kg/l
1.0
1.0
0.29
112
779
(40768793) Breast Pathology biopsy report
16
329
0.48
2.29
1.3
1.3
—
—
—
0
0
(3019174) dRVVT (LA screen)
6
13
4.62
2.27
1.5
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
79
564
1.41
2.26
2.9
2.6
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
24
127
1.90
2.26
1.0
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
26
142
1.84
2.23
2.2
1.5
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
14
60
2.34
2.21
1.3
1.1
mmol/l
1.6
1.5
—
6
43
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
19
93
2.05
2.21
4.1
2.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
19
93
2.05
2.21
4.1
2.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
47
304
1.56
2.19
1.2
1.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
25
136
1.85
2.17
1.2
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1833
19034
0.89
2.17
4.3
4.2
mmol/l
1.3
1.3
2.83
1600
16802
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
565
6279
0.87
2.16
2.9
3.3
ug/l
0.7
0.8
3.66
407
4561
(36660697) Celiac disease serology panel - Serum
160
1278
1.27
2.16
1.1
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
9
30
3.01
2.14
1.6
1.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
98
735
1.35
2.11
2.8
3.1
nmol/l
0.9
0.8
0.28
77
552
(3038071) Oxygen [Partial pressure] in Mixed venous blood
12
49
2.46
2.10
3.3
8.8
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
47
308
1.53
2.08
1.3
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
47
309
1.53
2.06
1.3
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
12
50
2.41
2.02
1.1
1.1
miu/ml
1730.5
1657.6
0.06
12
50
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
46
303
1.53
2.00
1.3
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
24
133
1.81
1.99
1.5
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
24
133
1.81
1.99
1.5
1.4
—
—
—
0
0
(3035611) Eosinophils/100 leukocytes in Synovial fluid
7
21
3.34
1.96
2.3
1.3
%
0.2
1.1
—
7
11
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
218
1824
1.21
1.95
1.8
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
46
305
1.52
1.95
1.3
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
46
305
1.52
1.95
1.3
1.4
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
51
0.00
1.88
0.0
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
611
5554
1.13
1.88
1.8
1.8
pmol/l
16468734.1
23158082.8
0.15
504
4478
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
12
4.17
1.82
1.4
1.6
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
23
130
1.78
1.81
2.9
1.7
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
33
207
1.60
1.79
1.2
1.3
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
95
1220
0.77
1.74
2.2
2.5
—
21.8
—
0
32
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
34
217
1.57
1.73
1.2
1.2
u/l
59.4
63.5
0.14
25
148
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
7
24
2.92
1.72
1.0
1.0
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
7
24
2.92
1.72
1.4
1.3
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
36
234
1.55
1.70
1.6
1.3
e6/l
111081.2
130586.0
0.06
24
162
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
19
104
1.83
1.67
1.4
1.8
u/l
11632.0
3077.6
—
7
33
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
49
342
1.44
1.66
1.0
1.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
8
31
2.59
1.66
1.9
1.4
umol/l
42.5
46.6
—
8
31
(3001729) Color of Synovial fluid
7
25
2.80
1.65
2.4
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
30
189
1.59
1.63
1.8
1.6
%
10.0
10.7
0.43
30
189
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
8
32
2.50
1.59
2.3
2.5
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
8
33
2.43
1.53
2.3
2.5
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
5
15
3.34
1.52
1.0
1.0
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
62
462
1.35
1.47
1.2
1.2
u/l
59.3
46.7
0.14
55
396
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
6
22
2.73
1.43
1.0
1.5
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
23
141
1.64
1.41
1.6
1.7
u/field
2.2
2.7
0.14
17
98
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
311
2761
1.14
1.41
3.0
3.9
ug/l
19.8
24.3
0.22
263
2312
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
6
23
2.61
1.36
1.2
1.1
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
15
82
1.83
1.35
1.3
1.2
g/l
34.5
39.7
—
6
38
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
17
97
1.76
1.34
1.2
1.3
ug/l
268.0
80.6
—
6
50
(3035320) C reactive protein [Mass/volume] in Body fluid
25
159
1.58
1.34
2.8
2.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
58
438
1.33
1.30
1.8
1.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1562
15076
1.08
1.29
3.9
3.7
pmol/l
14.9
15.1
1.64
1414
13276
(3020393) Adenovirus Ag [Presence] in Stool
5
18
2.78
1.28
1.0
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
91
732
1.25
1.27
1.4
1.2
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
6
25
2.40
1.24
2.7
2.8
mmol/l
1.6
3.4
—
6
20
(40761511) CBC panel - Blood by Automated count
2153
21076
1.09
1.23
27.4
17.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
12
63
1.91
1.22
1.1
1.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
14
78
1.80
1.21
1.4
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
13
71
1.83
1.19
1.6
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
47
349
1.35
1.19
2.2
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
220
1934
1.15
1.18
1.4
1.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
223
1963
1.15
1.18
3.8
3.7
ng/l
92.0
99.2
0.64
198
1652
(3045142) Bone marrow Pathology biopsy report
40
290
1.38
1.17
1.5
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1061
11101
0.93
1.14
4.5
5.6
ug/l
3.8
4.5
0.24
904
9820
(3033705) Calcium.ionized [Moles/volume] in Venous blood
52
396
1.32
1.13
4.1
2.5
—
—
—
0
0
(3002256) Pathology report gross observation
269
3000
0.89
1.13
1.4
1.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
442
4067
1.10
1.12
29.1
30.7
inr
1.5
1.5
0.18
49
554
(3022145) Colonoscopy Study observation
257
2294
1.13
1.11
1.3
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
893
8474
1.08
1.11
2.6
2.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
63
494
1.28
1.11
1.6
1.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
21
135
1.56
1.11
1.5
2.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
64
504
1.28
1.09
1.2
1.3
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
8
41
1.95
1.08
2.4
1.0
umol/l
16.2
16.8
—
8
35
(40768800) Prostate Pathology biopsy report
56
716
0.78
1.08
1.1
1.2
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
19
120
1.59
1.08
1.2
1.3
nmol/l
1.0
1.1
0.19
14
87
(3051387) C reactive protein [Mass/volume] in Capillary blood
44
581
0.75
1.08
5.4
3.7
mg/l
24.9
31.7
1.05
36
370
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
7
32
2.19
1.08
1.4
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
13
74
1.76
1.06
1.5
1.7
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
117
988
1.19
1.06
2.8
3.1
pmol/l
4.2
4.4
0.58
107
842
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
10
52
1.93
1.06
2.0
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
118
1386
0.84
1.03
5.3
3.9
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
79
645
1.23
1.01
1.7
1.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
24
163
1.48
1.01
1.3
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
22
147
1.50
1.00
1.1
1.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
24
338
0.71
0.91
1.3
1.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1895
19350
0.94
0.91
29.2
17.2
ml/min/173m2
71.6
71.7
0.07
1697
16042
(3017446) Testosterone [Moles/volume] in Serum or Plasma
186
1653
1.13
0.90
3.1
2.1
nmol/l
12.6
11.8
0.68
164
1399
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
9
152
0.59
0.88
1.0
1.1
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
6
31
1.94
0.84
6.8
13.0
mmol/l
6.0
5.8
—
6
31
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
13
203
0.64
0.84
1.4
1.4
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
6
113
0.53
0.83
1.3
1.1
mg/l
38.2
44.1
—
6
94
(3021960) Folate [Moles/volume] in Serum or Plasma
672
6379
1.07
0.82
1.7
1.6
nmol/l
18.0
19.8
2.74
610
5369
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
6
32
1.88
0.81
1.3
2.6
u/field
0.2
0.5
—
6
32
(3035933) Granulocytes/100 leukocytes in Blood
6
32
1.88
0.81
1.7
1.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
32
1.88
0.81
1.3
1.8
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
11
176
0.62
0.79
1.2
1.4
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
96
0.52
0.78
1.0
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
100
0.50
0.77
1.0
1.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
37
287
1.29
0.77
1.3
2.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
16
107
1.50
0.76
1.2
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
36
279
1.29
0.75
1.2
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
28
209
1.34
0.75
1.0
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
13
83
1.57
0.75
3.2
2.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
5
24
2.09
0.74
1.6
1.7
—
—
—
0
0
(4024509)
31
236
1.32
0.74
1.8
1.6
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
5
25
2.00
0.72
3.2
1.6
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
9
56
1.61
0.72
1.9
1.4
—
—
—
0
0
(3036603) Volume of Urine
20
142
1.41
0.72
1.7
1.3
ml
1700.6
1665.8
—
7
42
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
20
142
1.41
0.72
1.5
1.2
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
6
110
0.54
0.72
1.3
1.1
mg/l
205.7
286.3
—
6
94
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
57
686
0.83
0.71
3.5
3.7
u/ml
102.0
83.1
0.15
57
663
(3023511) Choriogonadotropin [Units/volume] in Urine
7
40
1.75
0.71
1.1
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
19
134
1.42
0.71
1.2
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
19
134
1.42
0.71
1.2
1.3
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
32
410
0.78
0.70
1.1
1.3
e6/l
10.8
33.4
0.79
23
327
(3015183) Erythrocyte sedimentation rate
9
58
1.55
0.69
1.3
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
549
5210
1.07
0.69
1.5
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
31
239
1.30
0.69
3.0
2.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
7
42
1.67
0.68
3.9
8.8
—
—
—
0
0
(3019225) pH of Specimen
238
2586
0.91
0.68
5.5
4.7
—
—
—
0
0
(4281824)
13
192
0.68
0.68
1.0
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
46
562
0.82
0.68
3.1
2.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1076
10421
1.05
0.67
5.1
4.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
112
988
1.14
0.66
1.1
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
67
785
0.85
0.64
6.2
4.6
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
32
251
1.28
0.64
1.1
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
101
889
1.14
0.62
3.5
2.9
g/l
0.5
0.3
0.94
48
357
(3044007) Cell count panel - Peritoneal fluid
10
63
1.59
0.61
1.8
2.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
43
352
1.23
0.61
2.0
2.3
mg/l
23.1
24.1
0.04
13
79
(3001019) Free T4 and TSH panel - Serum or Plasma
29
368
0.79
0.61
1.6
1.7
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
20
0.00
0.60
0.0
1.7
—
7.8
—
0
14
(3044640) Blood type and Crossmatch panel - Blood
764
7354
1.05
0.60
3.0
2.7
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
17
122
1.40
0.60
1.0
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
1.4
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
17
231
0.73
0.58
1.5
1.3
nmol/l
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
7
115
0.61
0.57
1.4
1.0
—
—
—
0
0
(3035880) pH of Pleural fluid
25
193
1.30
0.57
1.4
1.3
—
—
—
0
0
(44813793)
14
98
1.43
0.56
1.1
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
14
194
0.72
0.54
2.1
1.7
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
6
38
1.58
0.54
1.3
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
32
258
1.24
0.53
1.4
1.2
—
—
—
0
0
(3016750) Collection duration of Urine
21
161
1.31
0.51
1.7
2.0
min
510.8
494.7
0.31
13
115
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
17
126
1.35
0.51
1.2
1.5
umol/l
14.6
15.4
0.14
17
116
(3049717) Cytology report of Urine Cyto stain
118
1304
0.90
0.51
2.7
2.8
—
—
—
0
0
(4094501)
46
542
0.85
0.50
1.1
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
20
153
1.31
0.50
2.5
2.4
—
—
—
0
0
(1002224) Polysomnography panel
39
465
0.84
0.49
1.0
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
107
0.65
0.48
1.0
1.1
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
7
110
0.64
0.48
1.9
1.7
nmol/l
21.0
15.3
—
7
98
(3006270) Folate [Moles/volume] in Blood
29
236
1.23
0.46
1.1
1.2
nmol/l
275.4
333.4
0.75
22
185
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1930
19544
0.96
0.46
6.8
6.7
mmol/mol
41.9
41.2
2.13
1757
17672
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
7
49
1.43
0.46
2.1
1.8
mmol/l
1.1
1.2
—
7
49
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
13
94
1.38
0.46
1.8
1.4
g/l
1.0
0.9
0.18
13
94
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
61
695
0.87
0.45
2.2
2.3
ug/min
140.9
94.4
0.43
35
414
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
19
242
0.78
0.44
1.5
1.2
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
11
78
1.41
0.43
1.9
1.2
%
41.9
65.1
1.37
11
66
(3008898) HLA-B27 [Presence]
32
381
0.84
0.42
1.1
1.1
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.1
—
80.4
—
0
10
(3013512) EKG study
749
7276
1.04
0.41
5.5
4.5
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
24
195
1.23
0.40
1.2
1.2
mmol/l
7.9
7.9
0.01
17
134
(3010813) Leukocytes [#/volume] in Blood
2226
22450
0.96
0.40
44.7
26.2
e9/l
8.0
7.0
58.09
2176
21603
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
2226
22449
0.96
0.39
45.0
26.3
g/l
131.7
132.7
2.42
2194
21962
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
2226
22446
0.96
0.39
44.7
26.1
e12/l
4.4
4.4
2.04
2176
21605
(3035941) MCH [Entitic mass]
2226
22445
0.96
0.38
44.4
26.0
pg
30.6
30.5
1.42
2195
21949
(3024731) MCV [Entitic volume]
2226
22444
0.96
0.38
44.5
26.1
fl
92.8
91.8
15.86
2194
21949
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
9
66
1.36
0.38
1.1
1.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
2226
22443
0.96
0.38
44.7
26.1
e9/l
241.9
236.2
3.50
2182
21703
(3032057) Clostridioides difficile [Presence] in Stool
9
67
1.34
0.38
1.7
1.8
—
—
—
0
0
(4034850)
77
695
1.11
0.37
11.0
12.1
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
75
677
1.11
0.37
5.3
3.4
mmol/l
1.7
1.7
0.30
75
664
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
33
281
1.18
0.36
1.1
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
78
0.64
0.35
1.0
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
15
190
0.79
0.35
1.1
1.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
14
108
1.30
0.35
1.0
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
6
43
1.40
0.35
1.2
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
9
126
0.71
0.35
1.6
1.8
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
2211
21937
1.04
0.34
36.9
21.4
mmol/l
138.8
139.6
31.16
2173
21306
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
13
100
1.30
0.33
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
13
100
1.30
0.33
1.0
1.0
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
21
253
0.83
0.33
1.1
1.3
pmol/l
272.6
273.4
0.00
16
192
(3013139) Helicobacter pylori Ag [Presence] in Stool
115
1237
0.93
0.32
1.2
1.3
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
6
47
1.28
0.32
1.0
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
10
74
1.35
0.32
1.6
2.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
11
83
1.33
0.32
3.1
2.7
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
8
106
0.75
0.29
1.5
1.4
%
14.4
21.1
—
8
96
(3023103) Potassium [Moles/volume] in Serum or Plasma
2212
21969
1.03
0.28
37.0
21.6
mmol/l
4.0
4.0
3.75
2173
21309
(3006653) Thiamine [Moles/volume] in Blood
8
111
0.72
0.28
1.0
1.2
nmol/l
122.5
136.0
—
8
111
(3045683) HLA typing for celiac disease panel - Blood or Tissue
8
62
1.29
0.28
1.0
1.0
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
8
63
1.27
0.27
1.0
1.4
%
26.3
27.6
—
8
43
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
117
0.77
0.27
1.0
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
24
205
1.17
0.27
1.0
1.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
8
66
1.21
0.26
1.8
2.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
12
149
0.80
0.25
1.7
1.7
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
13
105
1.24
0.24
1.0
1.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
9
77
1.17
0.24
1.1
1.2
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
69
639
1.08
0.23
5.7
3.5
mmol/l
7.6
7.8
0.39
69
626
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
144
1514
0.95
0.23
1.4
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1068
10530
1.02
0.23
2.2
2.1
pmol/l
87.2
92.0
2.69
591
5547
(3014271) Vancomycin [Susceptibility]
21
181
1.16
0.22
2.6
3.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
49
534
0.92
0.21
1.7
1.5
—
—
—
0
0
(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.5
—
22.5
—
0
6
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.3
—
0.4
—
0
5
(4146454)
33
296
1.12
0.21
2.4
2.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
8
102
0.78
0.21
1.9
2.5
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
48
1.25
0.20
1.8
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
16
136
1.18
0.20
1.3
1.6
u/l
14.1
7.2
—
7
67
(3016879) Cocaine [Presence] in Urine
12
144
0.83
0.19
1.4
1.7
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
6
50
1.20
0.19
1.3
1.0
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
28
250
1.12
0.19
1.9
2.1
u/field
2.1
1.9
0.09
15
85
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
573
5628
1.02
0.18
3.0
2.5
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
24
268
0.89
0.17
2.0
1.5
pmol/l
156.7
325.0
1.62
24
263
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
20
226
0.88
0.17
1.5
1.6
u/ml
17.8
28.9
—
5
51
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
67
0.75
0.17
1.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
68
0.73
0.17
1.0
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
528
5374
0.98
0.16
1.8
1.6
mmol/l
1.4
1.3
1.57
442
4433
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
70
0.71
0.16
1.0
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
8
68
1.18
0.16
1.4
1.4
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
8
69
1.16
0.16
1.0
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
55
586
0.94
0.15
1.5
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
169
1635
1.04
0.15
4.5
3.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
9
79
1.14
0.15
1.1
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
75
712
1.05
0.15
1.1
1.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
15
131
1.15
0.14
1.5
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
35
378
0.92
0.14
1.1
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2186
21777
1.02
0.13
21.0
11.1
u/l
23.8
25.0
2.62
2144
20734
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
8
99
0.81
0.13
3.7
6.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
9
109
0.83
0.13
1.1
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
87
903
0.96
0.11
1.1
1.2
iu/ml
134.7
129.4
0.05
27
314
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
10
86
1.16
0.11
1.7
1.8
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
217
2129
1.02
0.09
4.3
3.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
29
272
1.07
0.09
1.7
1.5
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
6
57
1.05
0.08
1.7
1.5
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
62
0.81
0.08
1.0
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
14
154
0.91
0.08
1.4
1.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
14
154
0.91
0.08
1.4
1.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
30
283
1.06
0.08
1.4
1.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
9
84
1.07
0.07
1.2
1.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
10
89
1.12
0.06
1.1
1.6
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
25
236
1.06
0.06
1.9
2.2
ml
475.5
633.4
1.57
16
142
(3027944) Amphetamines [Presence] in Urine
14
152
0.92
0.06
1.4
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
14
151
0.93
0.05
1.4
1.7
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
18
169
1.07
0.05
5.7
15.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1875
18712
1.01
0.05
4.9
4.6
mu/l
2.1
2.1
0.22
1700
16594
(3020564) Creatinine [Moles/volume] in Serum or Plasma
2186
21827
1.01
0.04
36.7
21.3
umol/l
88.6
86.7
1.35
2186
21820
(3003338) MCHC [Mass/volume]
1632
16283
1.01
0.04
41.5
23.8
g/l
329.3
331.5
18.74
1614
16080
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
28
270
1.04
0.03
1.0
1.1
iu/ml
1.5
56.5
—
8
46
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
71
722
0.98
0.03
1.3
1.5
—
—
—
0
0
(44806420)
10
108
0.93
0.03
2.1
2.5
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
15
142
1.06
0.02
2.6
5.0
u/ml
134.0
25.2
—
5
40
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
68
670
1.02
0.02
1.3
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
11
115
0.96
0.00
1.5
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
11
115
0.96
0.00
1.5
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
12
115
1.04
0.00
6.3
4.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
23
229
1.00
0.00
1.3
1.5
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
43
429
1.00
0.00
1.8
1.3
nmol/l
1.0
0.8
0.60
33
343
(3045414) Leukocytes [Presence] in Urine
99
995
0.99
0.00
2.7
2.0
—
—
—
0
0
(4211845)
13
126
1.03
0.00
6.0
3.8
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
38
382
0.99
0.00
2.0
1.6
iu/l
4.9
4.2
0.27
13
111
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
98
977
1.00
0.00
2.4
3.1
u/ml
343.3
2657.3
1.14
76
836
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
11
107
1.03
0.00
1.1
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
60
1.00
0.00
1.8
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
5
51
0.98
0.00
2.0
2.6
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
5.2
—
376.6
—
0
5
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
6
0.00
0.00
0.0
6.8
—
67.0
—
0
6
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
6
0.00
0.00
0.0
1.2
—
7.9
—
0
6
(4133840)
5
49
1.02
0.00
1.0
1.1
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
24.1
—
0
9
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
1478.7
—
0
6
(3009677) Dengue virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
7
73
0.96
0.00
2.4
2.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
14
140
1.00
0.00
1.5
1.6
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
2.7
—
0
9
(3049242) von Willebrand panel - Platelet poor plasma
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
209.7
—
0
7
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.8
—
23.8
—
0
9
(3017937) Magnesium [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
8
85
0.94
0.00
1.0
1.1
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
5
0.00
0.00
0.0
9.6
—
—
—
0
0
(3002568) Complement factor B [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
0.2
—
0
6
(3028707) Methadone [Presence] in Urine by Screen method
7
75
0.93
0.00
1.7
2.1
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint IPF and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| IPF | 3.691 [3.29, 4.14] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.045 |
During the follow-up period (1.1.1998 — 31.12.2019), 3391 out of 5474 females with IPF died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| IPF | 3.607 [3.15, 4.13] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 5042 out of 7688 males with IPF died.
Mortality risk
Mortality risk for people of age
years, who have IPF.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.269% | 0.673% |
| 5 | 1.736% | 3.833% |
| 10 | 4.577% | 9.627% |
| 15 | 8.667% | 17.651% |
| 20 | 15.51% | 28.109% |
Relationships between endpoints
↥Index endpoint: IPF – Idiopathic pulmonary fibrosis
GWS hits: 13
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data